In 8-week-old mice with dilated cardiomyopathy induced by muscle-specific manganese superoxide dismutase deficiency (MnSOD-cKO), empagliflozin upregulated oxidative phosphorylation, increased survival, and prevented cardiac fibrosis [40]. Here, SOD2 is linked to fibrosis.